![](/img/cover-not-exists.png)
PCV117 COST-UTILITY OF BOSENTAN IN THE FIRST-LINE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN FINLAND—A DISCRETE EVENT SIMULATION MODELLING
EJ Soini, MD Stevenson, JA Martikainen, RL AkehurstVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74644-1
File:
PDF, 72 KB
english, 2009